Cita APA

Prasad, V., Huang, K., Prasad, S., Makowski, M. R., Czech, N., & Brenner, W. (2021). In Comparison to PSA, Interim Ga-68-PSMA PET/CT Response Evaluation Based on Modified RECIST 1.1 After 2(nd) Cycle Is Better Predictor of Overall Survival of Prostate Cancer Patients Treated With (177)Lu-PSMA. Front Oncol.

Chicago Style Citation

Prasad, Vikas, Kai Huang, Sonal Prasad, Marcus R. Makowski, Norbert Czech, i Winfried Brenner. "In Comparison to PSA, Interim Ga-68-PSMA PET/CT Response Evaluation Based On Modified RECIST 1.1 After 2(nd) Cycle Is Better Predictor of Overall Survival of Prostate Cancer Patients Treated With (177)Lu-PSMA." Front Oncol 2021.

Cita MLA

Prasad, Vikas, et al. "In Comparison to PSA, Interim Ga-68-PSMA PET/CT Response Evaluation Based On Modified RECIST 1.1 After 2(nd) Cycle Is Better Predictor of Overall Survival of Prostate Cancer Patients Treated With (177)Lu-PSMA." Front Oncol 2021.